Photo of Fay L. Szakal

Partner, Corporate, Healthcare and Real Estate Departments

Ms. Szakal focuses her practice in corporate, real estate and healthcare transactions. Her work encompasses the drafting and negotiation of corporate agreements and contracts, including those related to mergers and acquisitions of business entities, corporate and company formation, real estate and redevelopment matters, healthcare and private equity deals, financing matters, and other commercial transactions. Ms. Szakal has experience closing multi-million dollar development project deals involving a broad range of interested parties and complicated transactional issues related to the organization and operation of newly formed companies.

Prior to joining the firm, Ms. Szakal worked for a boutique New Jersey law firm where she split her practice between corporate transactional work and litigation. As a litigator, she provided representation in all aspects of litigation, including pre-litigation counseling, settlement negotiation, motion practice and appellate and Supreme Court advocacy, including successfully petitioning for certification to the New Jersey Supreme Court and overturning an adverse opinion. In addition, she represented a variety of public entity clients as special counsel, litigation counsel, substitute township attorney, and redevelopment counsel.

Results may vary depending on your particular facts and legal circumstances.

Contact information:

fszakal@greenbaumlaw.com | 732.476.3204 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

The federal Corporate Transparency Act (CTA) requires many business entities to disclose information about their business ownership to FinCEN.  Healthcare entities should note that the CTA does not have an exemption for healthcare practitioners, and so small to mid-size healthcare practices of all kinds, as well as practices falling into the “friendly PC” model, are

California Governor Gavin Newsom has signed into law a controversial bill, AB 2098, giving the Medical Board of California and the Osteopathic Medical Board of California the authority to investigate, challenge and rescind the licenses of California physicians and surgeons who engage in “unprofessional conduct” with regard to disseminating “misinformation or disinformation” related to COVID-19.